Product Information
Traditional Quantitative Testing Methods
Screening and monitoring of CKD needs quantitative measurement of urinary albumin. While standard tests in hospital are expensive and time-consuming, and no rapid test on the market provides quantitative measurement for CKD.
Cimple Solution
Quantitative Rapid Test (Platform technology). The first quantitative rapid test product for home users.
Technology System
Trapping length at different target concentrations
Visible to the naked eye
Technical Advantages
-
Personal health database easily built with a simple shooting
-
Provide health risk warning to the customers when their data is over the standard
Product Ecosystem - Home Test
2. Observation:
Observe the trapping length on the lit to recognize the value.
1. Apply Test Kit:
The sampling port comes into contact with the sample to complete a fixed-volume sampling
3. Judging Standard:
The trapping length recognization based on the standards
20 mg/L
150 mg/L
Normal
Microalbuminuria (Curable)
Macroalbuminuria (Untreatable)
Product Ecosystem - Suitable for Urine, Tissue Fluid, and Blood
-
Chronic kidney disease:
Urinary Albumin Creatinine
-
Ovulation Detection:
Luteinizing Hormone (LH)
-
Vaccine Antibody Detection
-
Liver Cancer:
AFP
-
Diabetes:
Glycated hemoglobin (GHb)
-
Melanoma:
S100A1
-
Prostate Cancer:
PSA
Project Milestone
R&D of technologies for heavy metal ions detection, COVID-19 antibody testing, and publication of research papers
-
Company Establishment
-
Product Prototype Optimization
-
Lunch and Standardized the products in Hong Kong and Mainland China
-
Apply for medical device licenses in European Union and the United States
-
Apply for medical device license in China
-
Confirming the production method
-
HK Tech 300 Angel Fund 1 million HKD
-
HKSTP Incu-Bio 6 million HKD
-
HK Tech 300 Seed Fund: HKD 100,000
-
HKSTP Ideation Programme: HKD 100,000